● Full-Spectrum RCM Solutions

Rheumatology Billing That Maximizes Every Biologic Dollar

Rheumatology billing is among the most high-value and high-complexity in medicine — spanning biologic infusion therapy, DMARD monitoring, joint injections, and autoimmune disease management with intensive prior authorization and step therapy requirements. RWG Life Sciences captures every dollar your practice earns.

Get a Free Consultation
Our Services

Step Therapy Appeals

DMARD failure docs experts

Biologic & Infusion Experts

J-code & buy-and-bill specialists

24-Hr Auth Management

Rapid biologic auth processing

Real-Time Infusion

Drug cost vs. reimbursement

● Specialty Overview

Why Rheumatology Billing Demands Specialized Expertise

Rheumatology practices generate some of the highest per-encounter revenue in outpatient medicine — driven by biologic infusion therapy where a single infusion visit can involve $10,000–$50,000+ in drug costs requiring precise J-code assignment, buy-and-bill protocols, and step therapy documentation to secure reimbursement.

Biologic Drug & Buy-and-Bill Infusion Billing

Biologic Drug & Buy-and-Bill Infusion Billing Biologics administered in-office require simultaneous J-code drug billing.

Step Therapy & Prior Authorization Management

Biologic therapies require documentation proving conventional DMARD therapy failure — often involving specific drug names, dates, durations, and clinical response data.

Joint Injection & Aspiration Coding

Arthrocentesis and corticosteroid injections must be coded by joint category (small, intermediate, or major) with correct drug codes and imaging guidance add-ons

Chronic DMARD Lab Monitoring Billing

Patients on methotrexate, hydroxychloroquine, and other DMARDs require regular CBC, CMP, and liver function monitoring — lab orders that must be correctly linked to appropriate diagnosis codes

End-to-End Coverage

HIPAA Compliant

24-Hour Turnaround

Real-Time Dashboards

● Common Challenges

Rheumatology Billing Challenges Costing Your Practice Revenue

Rheumatology practices face billing challenges that generate losses far larger per encounter than most specialties.
Each of these represents a solvable, specialty-specific problem with the right billing partner.

Missing Infusion Add-On Codes

Biologic infusions involving subsequent hours require add-on code 96415 for each additional hour beyond the initial 96413 code — yet many billers submit only the initial infusion code, systematically underbilling every multi-hour infusion session across the entire patient panel.

Add-on code omissions: $150–$400

Joint Injection Code Misclassification

Joint injections are coded by anatomical joint size — 20600 (small), 20605 (intermediate), 20610 (major) — and must reflect whether the procedure is performed with or without ultrasound guidance. Incorrect size classification or omitted guidance codes reduce reimbursement on every injection performed.

Injection misclassification: $50–$200

Biologic Prior Authorization Denials

Insurers require extensive clinical documentation before approving biologic therapies — including specific DMARD failure evidence, disease activity scores, and lab results. Incomplete or imprecise prior authorization submissions lead to denials that delay patient care and cost the practice tens of thousands per case.

Biologic auth denials: avg $12,000–$50,000

Step Therapy Documentation Gaps

Payers require proof of conventional DMARD therapy failure before approving biologic escalation. Insufficient documentation of drug names, trial durations, doses, and discontinuation reasons creates step therapy appeal failures that can permanently block biologic approval for affected patients.

Therapy gaps block 25%+ of first-line biologic

Incorrect Drug J-Code Assignment

Each biologic medication has a specific HCPCS J-code (e.g., J0129 for abatacept, J0135 for adalimumab) with per-unit dosing specifications. Incorrect J-code assignment or dose unit errors cause claim rejections or underpayments on your highest-value per-encounter services.

J-code errors cause biologic underpayment

High-Complexity E/M Undercoding

Rheumatology encounters managing multiple autoimmune conditions — RA, lupus, vasculitis, Sjögren's — routinely qualify for 99214 or 99215 based on high medical complexity. Generic billers default to lower-level codes, systematically undercollecting on every chronic disease management visit.

E/M undercoding: $40–$120 lost per rheum

● Our Rheumatology Billing Solutions

Purpose-Built Billing Solutions for Rheumatology Practices

Our rheumatology billing program is purpose-built for the unique financial complexity of autoimmune disease
management — addressing every revenue source from biologic infusions to chronic disease

Prior Authorization & Step Therapy

We build and submit comprehensive biologic prior authorization packages — including DMARD failure documentation, disease activity scores, lab evidence, and clinical notes — maximizing first-submission approval rates and reducing treatment delays for your patients.

Learn more

Joint Injection & Aspiration Billing

All joint injections and aspirations are coded to the correct anatomical joint size category — with ultrasound or fluoroscopy guidance add-ons properly billed when performed, and corticosteroid drug J-codes paired to every injection claim to capture full reimbursement.

Learn more

Biologic Infusion & J-Code Billing

We manage the complete biologic infusion billing workflow — correct J-code assignment with per-unit dosing, initial and add-on administration code sequencing (96413+96415), NDC documentation, and drug acquisition cost billing across every biologic agent your practice administers.

Learn more

DMARD & Lab Monitoring Billing

All DMARD monitoring laboratory orders are billed with correct long-term drug use ICD-10 codes, ordering physician NPI linkage, and payer-specific frequency justification — preventing denials on routine CBC, CMP, and liver function tests ordered for patient safety compliance.

Learn more

Denial Management & Step Therapy

All denied biologic claims receive comprehensive appeals with clinical literature support, DMARD failure documentation, disease activity scores, and peer-to-peer escalation — including external appeals when internal denial is upheld on insufficient clinical grounds.

Learn more

Infusion Suite Revenue Analytics

Live dashboards tracking infusion suite revenue per drug, per patient, and per payer — including drug acquisition cost vs. reimbursement margin analysis that helps your practice identify the most profitable biologic protocols and optimize your infusion therapy program.

Learn more

● Measurable Outcomes

What Rheumatology Practices Gain With RWG Life Sciences

Biologic infusion therapy represents your practice's highest-value revenue stream — and its highest billing risk. Our specialty-trained team protects and maximizes every dollar from every infusion, injection, and office visit.

35% Average Revenue Increase for Rheumatology Practices

Capturing infusion add-on codes, optimizing J-code dosing accuracy, and closing prior auth gaps consistently produce above-average revenue lifts within the first 90 days of partnership.

97%+ First-Pass Biologic Claim Acceptance

Rheumatology-specific claim scrubbing — J-code validation, dosing unit verification, add-on code sequencing, and prior auth linkage — ensures clean submission on every high-value infusion claim.

37% Reduction in AR Days

Proactive prior authorization, same-day infusion charge submission, and systematic AR follow-up across all payers dramatically shortens the cash cycle on your highest-value patient encounters.

85%+ Step Therapy Appeal Success Rate

Our drug cost vs. reimbursement dashboards give your practice precise visibility into the financial performance of every biologic you administer — enabling informed formulary and protocol decisions.

First-Pass Claim Rate
0 %
Revenue Increase
0 %
Step Therapy Auth Success
0 +
Per Biologic Infusion Value
0 k+

● Our Process

Our 6-Step Rheumatology Billing Workflow

A precision billing workflow built around the clinical and financial complexity of autoimmune
disease management — from biologic authorization through infusion billing and chronic disease visit optimization.

Patient Eligibility

Insurance benefits verified with specific rheumatology formulary review — confirming biologic coverage tier, step therapy requirements, and infusion center authorization before prescribing.

Prior Authorization

Comprehensive PA packages built with DMARD failure documentation, disease activity scores, and supporting labs — submitted within 24 hours for fastest possible approval turnaround.

Coding with J-Codes

All infusion visits coded with correct J-code, per-unit dosing, 96413 primary administration, and 96415 add-on codes for each additional hour — plus E/M complexity coding for office visits.

NDC Documentation

Manufacturer invoice cost reconciled to J-code claims, NDC numbers documented per CMS requirements, and drug acquisition cost reporting filed to support appropriate drug reimbursement.

Infusion Suite Reporting

Monthly dashboards tracking infusion revenue by drug, payer, and patient — with drug margin analysis, authorization approval rates, and E/M coding distribution reports for continuous practice optimization.

● Why Choose RWG

Why Rheumatology Practices Trust RWG Life Sciences

Biologic infusion therapy is your practice's most valuable revenue stream — and its most
complex billing challenge. We're the specialty RCM partner built specifically to protect it.

Rheumatology Billing Team

Your practice is managed by billers who work exclusively in rheumatology — understanding every biologic J-code, step therapy protocol, infusion code sequence, and autoimmune diagnosis specificity that generic billers routinely miss or simplify incorrectly.

0 %
Rheum-focused account team

Industry-Leading Step Therapy

Our comprehensive DMARD failure documentation packages and clinical literature support achieve an 85%+ biologic authorization approval rate — the highest in the industry — protecting your patients' access to life-changing therapy.

0 %
Step therapy appeal success rate

Complete Biologic J-Code Expertise

We maintain current knowledge of every biologic agent's specific HCPCS J-code, per-unit dosing requirements, NDC documentation rules, and payer-specific reimbursement schedules — ensuring your highest-value claims are never underpaid due to coding errors.

0 +

Biologic J-codes mastered

Infusion Suite Revenue Optimization

Our drug cost vs. reimbursement analytics provide real-time visibility into your infusion program's financial performance — helping you identify the most profitable biologics, optimize protocols, and benchmark against specialty standards.

$ 0 k+

Protected per biologic case

Proven Rheumatology Results

Our rheumatology clients average 35% revenue growth within the first 90 days — driven by biologic infusion add-on recovery, J-code accuracy improvements, and step therapy authorization rates that keep patients on approved therapies.

+ 0 %

Average rheum revenue lift

Rheumatology EHR Integration

We integrate with all major rheumatology EHR platforms — Athenahealth, Epic, AdvancedMD, Rheumatology on Demand, Veradigm, and 40+ others — ensuring seamless charge capture from your clinical workflows without disruption to your practice operations.

0 +

EHR systems supported

● Start Today — No Commitment

Ready to Protect Your Biologic Infusion Revenue?

Get a free, no-obligation rheumatology billing audit from RWG Life Sciences. We'll identify exactly where your practice is losing revenue on biologic infusions, step therapy denials, joint injection coding, and lab monitoring — and show you precisely how to recover it.

 

Schedule Free Consultation